Nesso, Italy

Andrea Fasana

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrea Fasana: Innovator in Pharmaceutical Chemistry

Introduction

Andrea Fasana is a prominent inventor based in Nesso, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for synthesizing important compounds. With a total of 2 patents to her name, Fasana continues to push the boundaries of scientific research and innovation.

Latest Patents

Fasana's latest patents include a process for preparing (3α,5α)-3-hydroxy-3-methyl-pregnan-20-one, commonly known as Ganaxolone. This compound is crucial in various therapeutic applications. Another notable patent involves the synthesis of the sodium salt of 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)-phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]-butanoic acid, also known as Elagolix sodium salt. These inventions highlight her expertise in creating complex chemical compounds that have significant medical implications.

Career Highlights

Fasana is currently employed at Industriale Chimica S.r.l., where she applies her knowledge and skills to advance the company's research initiatives. Her work has been instrumental in developing new methodologies that enhance the efficiency and effectiveness of pharmaceutical production.

Collaborations

Throughout her career, Fasana has collaborated with notable colleagues, including Roberto Lenna and Jerry Ortiz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Andrea Fasana is a remarkable inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. Her contributions through her patents and collaborations continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…